Association between rs1800795 (-174 G/C) Polymorphism in the Promoter of <i>IL</i>6 Gene and Risk of Relapsing-Remitting Multiple Sclerosis (RRMS) in Isfahan Population

ISSN Print: 2162-4453
ISSN Online: 2162-4461
www.scirp.net/journal/ojgen
E-mail: [email protected]

Citations

"Association between rs1800795 (-174 G/C) Polymorphism in the Promoter of IL6 Gene and Risk of Relapsing-Remitting Multiple Sclerosis (RRMS) in Isfahan Population"
written by Meraj Pourhossein, Reza Ghavimi, Fereshteh Alsahebfosoul, Kamran Ghaedi,
published by Open Journal of Genetics, Vol.4 No.5, 2014

has been cited by the following article(s):

[1]	The Role of Plasma Interleukin-6 Levels on Atherosclerotic Cardiovascular Disease and Cardiovascular Mortality Risk Scores in Javanese Patients with Chronic …
	Journal of Personalized …, 2022

[2]	Dual Effect of IL-6-174 G/C Polymorphism and Promoter Methylation in the Risk of Coronary Artery Disease Among South Indians
	Indian Journal of Clinical Biochemistry, 2018

[3]	Interleukin-6 gene polymorphisms and serum erythropoietin and hemoglobin in hemodialysis Iraqi patients
	2018

[1]	The Palgrave Encyclopedia of Disability 2025 DOI:10.1007/978-3-031-40858-8_349-1

[2]	Exploring the Link Between IL-6 rs1800795 G > C SNP and the Severity of Epstein-Barr Virus-Associated Multiple Sclerosis: Potential Impact on Cognitive Impairment Molecular Neurobiology, 2025 DOI:10.1007/s12035-025-05211-x

[3]	Effects of Interleukin-10 (-1082/-819) and Interleukin-6 (-174) Gene Polymorphisms on Corpus Callosum Changes in Women with Multiple Sclerosis Journal of Gorgan University of Medical Sciences, 2024 DOI:10.61882/goums.26.4.38

[4]	The Role of Plasma Interleukin-6 Levels on Atherosclerotic Cardiovascular Disease and Cardiovascular Mortality Risk Scores in Javanese Patients with Chronic Kidney Disease Journal of Personalized Medicine, 2022 DOI:10.3390/jpm12071122

[5]	Dual Effect of IL-6 -174 G/C Polymorphism and Promoter Methylation in the Risk of Coronary Artery Disease Among South Indians Indian Journal of Clinical Biochemistry, 2018 DOI:10.1007/s12291-018-0740-3